Your privacy is important to us.
Hilary has extensive experience in all types of corporate finance, transactional and commercial work. This includes mergers and acquisitions, private equity and venture capital investment, corporate governance, reorganisations and restructurings, joint ventures and collaborations and commercial contracts. She also has unique experience in Northern Ireland of the higher education and life sciences sectors having spent 12 months leading the technology transfer team at Queens University, Belfast specialising in the development and commercialisation of Intellectual Property.
Their clients include a range of clients specifically in the agri business, manufacturing and life sciences sector such as Lakeland Dairies, Ulster Carpet Milk and Millicent Pharma (NI).
Hilary has also worked as course adviser and tutor at the Institute of Professional Legal Studies in Belfast in the area of advanced company law. She currently sits on the counsel for the Northern Ireland Chamber of Commerce.
Hilary Griffith acts for significant clients from a wide range of sectors on all manner of corporate transactions. She has “considerable corporate and M&A experience within Northern Ireland and beyond.” Clients note, “she has excellent advisory skills and a solution-orientated approach.” “She is able to explain complex legal issues in a clear and concise way.” “She provides succinct advice with a lot of commercial knowledge.”
Practice head Hilary Griffith has “excellent knowledge, commerciality and personal style.” Clients describe her as a “good leader who is excellent at business development and relationships.” She is an expert in IP issues relation to acquisitions and agreements, with a particular emphasis on the life sciences and technology sectors.
Hilary Griffith is described as a “strong practitioner.” Client praise her “clear-thinking” and “practical” approach. She is “capable of tailoring advice to an individual situation and explaining clearly.” As well as M&A, Hilary is also experienced in management buy-outs, fund raisings and private equity investments, with a particular focus on the life sciences, higher education and technology sectors.